JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Journal of the American College of Nutrition, Vol. 25, No. 6, 550 (2006)
Published by the American College of Nutrition

Conflict of Interest Disclosures Associated with JACN Volume 25, Number 3(S), June 2006

Alexander Logan MD, guest editor & introduction, pp. 165–169: Dr. Logan had sole responsibility for selecting the authors and choosing the topics for the sodium supplement. There was no input from ILSI or the salt industry. The topics were chosen to provide a comprehensive overview of sodium and human health. The authors were selected based on their reputation for scientific excellence and knowledge in the assigned topic.

Dr. Logan does not hold any research grants or receive research support from the food industry or any salt organization and has no ownership interests in any business related to the food or salt industries. Finally, while he provides consultative advice to many organizations including ILSI, he accepts no fee or honoraria and has no financial ties to ILSI.

Rick L. Sharp, pp. 231S–239S: Dr. Sharp formerly served as a paid consultant to the Campbell Soup Company. The study described in reference #38 (Ray et al. JAP, 1998) was supported by a research grant from Campbell Soup Company.

Norman K. Hollenberg, pp. 240S–246S: no conflicts to disclose.

Veronica Franco & Suzanne Oparil, pp. 247S–255S: Veronica Franco has no conflicts to disclose. Dr. Suzanne Oparil is the recipient of grants-in-aid from Abbott Laboratories, Astra Zeneca, Aventis, Biovail, Boehringer Ingelheim, Bristol Myers-Squibb, Forest Laboratories, GlaxoSmithKline, Novartis, Merck & Co., Pfizer, Sankyo Pharma, Sanofi-Synthelabo, Schering-Plough. She is a consultant for the Salt Institute, Bristol Myers-Squibb, Daiichi Sankyo, Merck & Co., Novartis, Pfizer, and Sanofi Aventis. She is a member of the Board of Directors for Encysive Pharmaceuticals.

Michael H. Alderman, pp. 256S–261S: Dr. Alderman is an unpaid consultant to the Salt Institute, regularly attending an annual consultant meeting. Approximately a decade ago he received a modest honorarium from the Salt Institute for a presentation; he has no present support from either the Salt Institute or any food or nutrition related company.

R. Curtis Morris, Jr., et al. pp. 262S–270S: no conflicts to disclose.

Robert P. Heaney, pp. 271S–276S: Dr. Heaney years ago received a modest honorarium for a presentation to the medical advisory panel of the Salt Institute. Since then he has had no relationship with the Salt Institute. He serves as a speaker for Merck & Co. and also serves on medical advisory panels for both IDFA and the National Dairy Council. He has done contract reviews for the dairy industry. Additionally, he presented lectures for Procter & Gamble/Alliance for Bone Health, mostly with respect to the importance of calcium and vitamin D.

Steven H. Woolf, pp. 277S–284S: no conflicts to disclose.





This Article
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS